AKAlexander N. Khokhlov

Alexander N. Khokhlov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexander N. Khokhlov has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Some Brief Remarks on Statistical Significance and “Trends” in Gerontological Research

    by A. N. Khokhlov

    Drawing on his editorial experience at relevant scientific journals and his experience in teaching the basics of scientific article formatting/design at Lomonosov Moscow State University, the author analyzes the current state of statistical analysis of results of the gerontological research aimed at understanding the mechanisms of aging and search for drugs that slow down this process and suppress the development of age-related diseases (geroprotectors, anti-aging drugs). It is emphasized that in many cases, such analysis is either not performed at all or is performed incorrectly. Specifically, authors periodically analyze data that does not follow a normal distribution using a parametric Student’s t-test. Moreover, many researchers, having failed to obtain reliable results (p > 0.05), increasingly replace the term “significance” in their articles with the term “trend,” which seems completely unacceptable. Unfortunately, this problem affects not only gerontology but all biomedical research. It is suggested that greater attention should be paid to this issue by both reviewers of relevant articles and editors of the journals in which they are published. In addition, the importance of teaching the basics of statistical processing of research results to students and PhD students of biomedical institutes and relevant university schools is emphasized.


  • Open Access

    Statistical analysis in biomedical research: From significance to “trends”?

    by A.N. Khokhlov

    Drawing on his many years of experience editing for biomedical journals and lecturing on scientific article formatting for PhD students at Lomonosov Moscow State University, the author analyzes the current state of statistical analysis of biological, biomedical, and medical research results - in particular, data obtained in studies aimed at discovering drugs that supposedly slow aging and suppress the development of age-related diseases. He emphasizes that in many cases, such analysis is either not performed at all or is performed incorrectly. Authors often analyze data that does not follow a normal distribution using the parametric Student’s t-test. Moreover, many researchers, having failed to obtain reliable results (p > 0.05), are increasingly replacing the term “significance” in their articles with “trend,” which seems completely unacceptable. This problem affects not only biomedical but also other natural science research, but it is especially important for biomedicine, as it is at stake in human life and health. It is proposed that greater attention should be paid to this issue by both reviewers of relevant articles and editors of the journals in which they are published. Furthermore, the importance of teaching the basics of statistical processing of research results to undergraduate and graduate students in biological, biomedical, and medical institutes, as well as relevant university schools, is emphasized.

  • Defining Aging: Past, Present, and Possible Future

    by A. N. Khokhlov

    Various views on the “correct” definition of aging are analyzed. It is emphasized that a huge number of such definitions have emerged in recent decades, and several million scientific publications devoted to this topic can be found online. At the same time, most gerontologists based their definitions on the premise that aging (with various modifications) is a set of age-related changes in the body that lead to an increased probability of death. However, as numerous new data emerged in gerontological research, many specialists began to question the suitability of this “classical” definition. This was due, among other things, to the identified impact of long-term chronic diseases such as HIV or COVID-19 on age-related mortality dynamics, to the dramatic changes in recent decades in the understanding of cellular aging and the relationship between aging and various age-related diseases, as well as to the correct methodology for determining biological age. The apparent lack of progress in fundamental gerontology to date and the emergence of a large number of studies in which the presence/absence of aging in the studied organisms was in no way linked to the obtaining survival curves also played a significant role. The evolution of approaches to defining aging is discussed, as well as potential future modifications to this definition.


  • Open Access

    The Renewed ‘Advances in Gerontology’ 2025: Results, Prospects, Changing Strategy

    by A. N. Khokhlov

    Editor-in-Chief of ‘Advances in Gerontology,’ who took over the journal in 2023, analyzes the path the journal has taken over the past 1.5 years and reflects on the prospects for its further development. It is emphasized that the initial idea, according to which the edition was to focus exclusively on articles on fundamental (molecular, biochemical, cellular, etc.) mechanisms of aging and longevity, apparently turned out to be untenable. It had to admit the importance of publishing articles in the journal that touch upon other areas of gerontological research, in particular—psychology, sociology, demography, and medicine. It is now becoming quite clear that such work is no less important for understanding the essence of aging, as well as for prolonging healthy life, than so-called fundamental research. And perhaps even more important. In this regard, the corresponding specialists were introduced to the Editorial Board. Gerontological works devoted to the problem of falls in the elderly are specially considered, their undoubted importance for the whole society is emphasized. It is noted that over the past time, the journal’s scientometric indicators have increased significantly, and the geography of the authors of the published articles has greatly expanded—including due to the increase in the number of research areas covered. It is emphasized that recently published works on the psychology and sociology of aging have become among the most viewed and downloaded articles of the edition. The author of this Editorial hopes that the growing interest in the journal will attract new researchers involved in both theoretical and experimental, as well as clinical or social gerontology.


  • Open Access

    Положение российских научных журналов по естественным, точным и техническим наукам в международных рейтингах

    by Galina V. Morgunova, А. Н. Хохлов, Alexander N. Khokhlov

    Place of Russian scientific journals on natural, exact, and technical sciences in the international rankings


  • Antioxidants: Good, Bad, or Ineffective in Terms of Aging and Lifespan? It Depends

    by A. N. Khokhlov

    The problem of antioxidant efficiency in terms of their impact on “normal” aging and age-related diseases is discussed. It is emphasized that for many years antioxidants were considered the most promising geroprotectors (anti-aging drugs) capable of slowing down aging, treating age-related diseases and increasing both the average and maximum lifespan of animals and humans. However, as noted, in recent years the situation has begun to change dramatically. The methodological aspects of this problem are considered—in particular, the complexity of the correct selection of effective concentrations of such drugs in experimental gerontological studies on both multicellular organisms and cell cultures is emphasized. The literature data is analyzed, indicating that, in many cases, antioxidants, unfortunately, can even be harmful to the body, causing “paradoxical” oxidative stress and suppressing some important physiological functions.


  • Open Access

    Aging, Cancer, Metformin, Light Regime, Advances in Gerontology, Books, Verses, Music, Fine Art, etc. etc. Remembering Prof. Vladimir N. Anisimov

    by A. N. Khokhlov, N. G. Kolosova, G. V. Morgunova

    Current editors of the journal Advances in Gerontology dedicate this short obituary paper to Prof. Vladimir N. Anisimov, one of the most famous and outstanding world gerontologists, the founder of this journal, who passed away on November 16, 2024. Vladimir Anisimov’s research interests and his contributions to both experimental and theoretical gerontology and oncology are briefly described. The authors also share their personal impressions from many years of communication with V.N. Anisimov. It is emphasized that, being an extremely versatile person, Prof. Anisimov was engaged not only in science, but also in literary work, wrote excellent books and verses, was interested in music and fine art. And, perhaps his most important characteristic, he possessed an incredible sense of humor, which the authors consider to be a necessary trait of any outstanding scientist.


  • Open Access

    DRUGS WITH SENOLYTIC ACTIVITY: PROSPECTS AND POSSIBLE LIMITATIONS

    by Г. В. Моргунова, A.N. Khokhlov

    The search and testing of drugs with senolytic activity is one of the new directions in gerontology. The number of “senescent” cells that increases with age contributes to the development of age-related diseases and chronic non-infectious inflammation. Removing “senescent” cells or suppressing their influence on surrounding tissues seems a logical step to improve the quality of life and, possibly, prolong lifespan. However, drugs that have senolytic and senomorphic activity in model systems cause the development of a number of side effects in clinical trials. In this review, we consider the main advances in the field of senotherapy, the prospects for the use of senotherapy drugs, and the limitations that researchers and clinicians may encounter.


  • Open Access

    Antioxidants: good, bad, or ineffective in terms of aging and lifespan? It depends

    by A. N. Khokhlov

    The problem of antioxidant efficiency in terms of their impact on “normal” aging and agerelated diseases is discussed. It is emphasized that for many years antioxidants were considered the most promising geroprotectors (anti-aging drugs) capable of slowing down aging, treating age-related diseases and increasing both the average and maximum lifespan of animals and humans. However, as noted, in recent years the situation has begun to change dramatically. The methodological aspects of this problem are considered – in particular, the complexity of the correct selection of effective concentrations of such drugs in experimental gerontological studies on both multicellular organisms and cell cultures is emphasized. The literature data is analyzed, indicating that, in many cases, antioxidants, unfortunately, can even be harmful to the body, causing “paradoxical” oxidative stress and suppressing some important physiological functions.